Efficacy and safety of long-term bisphosphonates in postmenopausal osteoporosis

By Miller Paul D  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2253-2258

Informa Healthcare

Access to resources Recommend Favorite

The Cost Effectiveness of Bisphosphonates for the Prevention and Treatment of Osteoporosis: A Structured Review of the Literature

By Fleurence Rachael L.  

PharmacoEconomics, Vol. 25, Iss. 11, 2007-01 ,pp. : 913-933

Adis International

Access to resources Recommend Favorite

Tolerability of Different Dosing Regimens of Bisphosphonates for the Treatment of Osteoporosis and Malignant Bone Disease

By Bobba Raja S.  

Drug Safety, Vol. 29, Iss. 12, 2006-01 ,pp. : 1133-1152

Adis International

Access to resources Recommend Favorite

Bisphosphonates in osteoporosis: recent clinical experience

By McClung M.R.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 225-238

Informa Healthcare

Access to resources Recommend Favorite

Does the Funding Source Influence the Results in Economic Evaluations?: A Case Study in Bisphosphonates for the Treatment of Osteoporosis

By Fleurence Rachael L.  

PharmacoEconomics, Vol. 28, Iss. 4, 2010-04 ,pp. : 295-306

Adis International

Access to resources Recommend Favorite